NCT07324239

Brief Summary

Evaluate the effect of TECAR therapy on pain, voiding, erectile function, sleep quality and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 23, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

January 2, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2026

Completed
Last Updated

January 7, 2026

Status Verified

December 1, 2025

Enrollment Period

3 months

First QC Date

December 23, 2025

Last Update Submit

December 23, 2025

Conditions

Prostatitis

Outcome Measures

Primary Outcomes (1)

  • Pelvic pain

    Pain will be assessed using the National Institutes of Health-Chronic Prostatitis Symptom Index

    Baseline and 8 weeks later

Secondary Outcomes (1)

  • Quality of life of men

    Baseline and after 8 weeks

Study Arms (2)

TECAR therapy group

ACTIVE COMPARATOR
Device: TECAR therapy

Control group

SHAM COMPARATOR
Device: Sham TECAR therapy

Interventions

TECAR therapyDEVICE

WINBACK 3SE (France) will be used for TECAR therapy in this study. To facilitate optimal distribution of endogenous heat therapy and effective contact between the active electrodes, both capacitive and resistive, and the surface of the skin, a layer of high-conductivity cream will be applied to the treatment region. The plate, an inactive electrode, which has a specific size (21cm\*15cm), will be placed on the gluteal region. The capacitive electrode was employed for a duration of seven and a half minutes, at an intensity of 30-40%, whereas the resistance electrode will be utilized for an equivalent period over the perineum at the same intensity.

TECAR therapy group
Sham TECAR therapyDEVICE

The procedure is similar to the active treatment of TECAR, but with the critical difference being that the output intensity of the TECAR device will be set to zero during the session.

Control group

Eligibility Criteria

Age30 Years - 50 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Presence of chronic prostatitis/chronic pelvic pain symptoms for more than 6 months.
  • Ages will be ranged from 30 to 50 years old.

You may not qualify if:

  • Urinary and seminal infections.
  • Recent parenteral steroid administration.
  • Prior prostate or pelvic surgery.
  • Lower urinary tract disorders such as bladder stones.
  • Implanted electronic devices as pacemakers.
  • Sensory loss over the perineum.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University Hospital

Tanta, Egypt

Location

MeSH Terms

Conditions

Prostatitis

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Mohammed Saif

    National institute for Gerontology

    STUDY DIRECTOR

Central Study Contacts

Saher Elgayar, Ph.D

CONTACT

+201020429911saherlotfy020@gmail.com

Mohammed Elhamrawy, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Physical Therapy

Study Record Dates

First Submitted

December 23, 2025

First Posted

January 7, 2026

Study Start

January 2, 2026

Primary Completion

April 1, 2026

Study Completion

April 7, 2026

Last Updated

January 7, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)